Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 10 Apr NANBIOSIS Unit 10 helps develop eye drops with adalimumab for retinitis pigmentosa, showing promising results in preclinical models. Vitoria, april 2025. A multidisciplinary team of researchers from the Centro de Investigación Biomédica en Red (CIBER), the Centro de Investigación Prínc[...] 08 Apr NANBIOSIS will join EBS2025 in Tarragona as organizer and sponsor, with a stand to showcase its services in biosensors and nanobiomedicine. Tarragona, october 2025. NANBIOSIS will be actively participating in the European Biosensors Symposium (EBS) 2025, which will take plac[...] 10 Apr NANBIOSIS Unit 10 helps develop eye drops with adalimumab for retinitis pigmentosa, showing promising results in preclinical models. Vitoria, april 2025. A multidisciplinary team of researchers from the Centro de Investigación Biomédica en Red (CIBER), the Centro de Investigación Prínc[...] 08 Apr NANBIOSIS will join EBS2025 in Tarragona as organizer and sponsor, with a stand to showcase its services in biosensors and nanobiomedicine. Tarragona, october 2025. NANBIOSIS will be actively participating in the European Biosensors Symposium (EBS) 2025, which will take plac[...] 10 Apr NANBIOSIS Unit 10 helps develop eye drops with adalimumab for retinitis pigmentosa, showing promising results in preclinical models. Vitoria, april 2025. A multidisciplinary team of researchers from the Centro de Investigación Biomédica en Red (CIBER), the Centro de Investigación Prínc[...] 08 Apr NANBIOSIS will join EBS2025 in Tarragona as organizer and sponsor, with a stand to showcase its services in biosensors and nanobiomedicine. Tarragona, october 2025. NANBIOSIS will be actively participating in the European Biosensors Symposium (EBS) 2025, which will take plac[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Latest From the Blog
Innovative eye drops offer new hope for Retinitis Pigmentosa patients
NANBIOSIS to participate in the new edition of the European Biosensors Symposium 2025
Innovative eye drops offer new hope for Retinitis Pigmentosa patients
NANBIOSIS to participate in the new edition of the European Biosensors Symposium 2025
Innovative eye drops offer new hope for Retinitis Pigmentosa patients
NANBIOSIS to participate in the new edition of the European Biosensors Symposium 2025
Units of Nanbiosis
About Nanbiosis
Responsive Design
HiDPi Ready
Drag’n’drop builder